Literature DB >> 908035

Ultrastructural comparison between cultured and tumor cells of human malignant melanoma.

C Foa, C Aubert.   

Abstract

Tumor cells from 28 human malignant melanomas were compared by electron microscopy with cultured cells of 17 established human melanoma cell lines derived from the same types of tumors. Both tumor and cultured cells were classified into five types according to their different fine-structural characteristics. There was a correlation between the cell types observed in the tumor fragments and in the cell lines. This evidence suggests that cultured human melanoma cells retained in vitro the characteristics of the melanoma cells in vivo, from which they were derived.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

Review 1.  The natural history of a family of transplantable melanomas in hamsters.

Authors:  A Bomirski; A Słominski; J Bigda
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

2.  Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.

Authors:  X Guo; Y P Zhang; D A Mitchell; D T Denhardt; A F Chambers
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

3.  Dual addressing of thymidine synthesis pathways for effective targeting of proliferating melanoma.

Authors:  Tara Miran; Andreas T J Vogg; Laila El Moussaoui; Hans-Jürgen Kaiser; Natascha Drude; Verena von Felbert; Felix M Mottaghy; Agnieszka Morgenroth
Journal:  Cancer Med       Date:  2017-06-13       Impact factor: 4.452

4.  Do cell lines in vitro reflect the properties of the tumours of origin? A study of lines derived from human melanoma xenografts.

Authors:  K M Tveit; A Pihl
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.